Global Ischemic Cerebral Stroke Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2029 |
 Market Size (Base Year) |
|
 Market Size (Forecast Year) |
|
 CAGR |
% |
| Major Markets Players |
|
>全球缺血性脑卒中市场，按药物类别（钙通道阻滞剂、血栓溶解剂等）、治疗（药物、手术等）、诊断（计算机断层扫描 (CT) 血管造影和 CT 扫描、颈动脉双重扫描、磁共振成像 (MRI)、数字减影血管造影等）、症状（突然发作偏瘫、四肢瘫痪和单轻瘫、单眼视力丧失、复视、视野缺损、偏身感觉缺损、构音障碍、面部下垂、眩晕、共济失调、眼球震颤、失语症、意识丧失等）、剂量（注射、片剂、其他）、给药途径（口服、静脉注射、其他）、最终用户（诊所、医院、其他）、分销渠道（医院药房、零售药房、在线药店）、国家（美国、加拿大、墨西哥、巴西、阿根廷、秘鲁、南美洲其他地区、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、匈牙利、立陶宛、奥地利、爱尔兰、挪威、波兰、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、越南、亚太其他地区、沙特阿拉伯、阿联酋、埃及、以色列、科威特、南非、中东和非洲其他地区）行业趋势和预测到 2029 年。
市场分析与洞察全球缺血性脑卒中市场
缺血性脑卒中市场预计将在 2022-2029 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在上述预测期内，市场复合年增长率将达到 7.07%。
缺血性脑卒中是指脑供血血管因血栓堵塞，导致神经功能丧失的疾病。突然出现偏瘫、四肢瘫痪、单侧瘫痪、单眼视力丧失、复视、视野缺损、偏身感觉障碍、构音障碍、面部下垂、眩晕、共济失调、眼球震颤、失语、意识状态下降等都是缺血性脑卒中的症状。
The rise in the prevalence of ischemic cerebral stroke will act as major driver that will results in the expansion of market’s growth. Another significant factor influencing the growth rate of ischemic cerebral stroke market is the rising healthcare expenditure. Furthermore, advancement in the medical technology, rising initiatives by public and private organisations to spread awareness and growing government funding are the factors that will expand the ischemic cerebral stroke market. Other factors such as increase in the demand for effective therapies and rising geriatric population will positively impact the ischemic cerebral stroke market’s growth rate. Additionally, high disposable income and surge in the adoption rate of sedentary lifestyle will result in the expansion of ischemic cerebral stroke market. Also, growing incidences high cholesterol, diabetes, high blood pressure and clotting disorders, alcohol abuse and high smoking consumption will cushion the growth of ischemic cerebral stroke market
Moreover, the rise in the investment level for research and development activities and emerging new markets will provide beneficial opportunities for the ischemic cerebral stroke market in the forecast period of 2022-2029. Also, high unmet need of current treatment and developments in healthcare technology will escalate the growth rate ischemic cerebral stroke market in future.
However, high cost associated with the treatment and lack of infrastructure in low-income countries will impede the growth rate of ischemic cerebral stroke market. Additionally, complications involved with ischemic cerebral stroke will hinder the ischemic cerebral stroke market growth. Less awareness and multiple patent expiries of branded drugs will further challenge the market in the forecast period mentioned above.
This ischemic cerebral stroke market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Ischemic cerebral stroke market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Ischemic Cerebral Stroke Market Scope and Market Size
The ischemic cerebral stroke market is segmented on the basis of drug class, treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of drug class, the ischemic cerebral stroke market is segmented into calcium channel blockers, thrombolytics and others.
- On the basis of treatment, the ischemic cerebral stroke market is segmented into medication, surgery and others.
- On the basis of diagnosis, the ischemic cerebral stroke market is segmented into computed tomography (CT) angiography and CT scan, carotid duplex scanning, magnetic resonance imaging (MRI), digital subtraction angiography and others.
- On the basis of symptoms, the ischemic cerebral stroke market is segmented into sudden onset of hemiparesis, quadriparesis, and monoparesis, monocular visual loss, diplopia, visual field deficits, hemisensory deficits, dysarthria, facial droop, vertigo, ataxia, nystagmus, aphasia, loss of consciousness and others.
- On the basis of dosage, the ischemic cerebral stroke market is segmented into injection, tablets and others.
- On the basis of route of administration, the ischemic cerebral stroke market is segmented into oral, intravenous and others.
- On the basis of end-users, the ischemic cerebral stroke market is segmented into clinic, hospital and others.
The ischemic cerebral stroke market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Ischemic Cerebral Stroke Market Country Level Analysis
Ischemic cerebral stroke market is analyzed and market size information is provided by the country, drug class, treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel as referenced above.
The countries covered in the ischemic cerebral stroke market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the ischemic cerebral stroke market due to the presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the increasing patient pool, rising investment in the healthcare sector and growing government support.
报告的国家部分还提供了影响单个市场因素和国内市场法规变化，这些变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、疾病流行病学和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、销售渠道的影响。
患者流行病学分析
缺血性脑卒中市场还为您提供详细的市场分析，包括患者分析、预后和治疗。患病率、发病率、死亡率、依从率是报告中提供的一些数据变量。分析流行病学对市场增长的直接或间接影响，以创建更稳健、更全面的多元统计模型，用于预测增长期的市场。
竞争格局和全球缺血性脑卒中市场份额分析
缺血性脑卒中市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、公司优势和劣势、产品发布、临床试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对缺血性脑卒中市场研究的关注有关。
缺血性脑卒中市场的一些主要参与者包括 F. Hoffmann-La Roche Ltd.、PLx Pharma Inc.、Johnson & Johnson Private Limited、Aurobindo Pharma、Teva Pharmaceutical Industries Ltd.、Sun Pharmaceutical Industries Ltd.、GlaxoSmithKline plc、Sanofi、Apotex Inc.、Amneal Pharmaceuticals LLC.、Dr. Reddy's Laboratories Ltd.、Pfizer Inc.、Mylan NV、Novartis AG、Bausch Health Companies Inc.、Zydus Cadila、Glenmark Pharmaceuticals Limited、Sofgen Pharmaceuticals、Arbor Pharmaceuticals 和 AbbVie Inc. 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
